IOC Certificate in Drugs in Sport
This IOC professional certificate course will train and equip healthcare professionals and those working in the anti-doping field to advise and support athletes to make the best choices regarding effective clinical drug options while ensuring compliance with the rules of the World Anti-Doping Code (WADC), sports federations, and national anti-doping agencies. It will also empower them to become educators and supporters to athletes and other athlete support personnel on anti-doping and clean sport matters, including the safe and informed selection of medications and supplements.
The course will introduce healthcare providers and anti-doping professionals to the key concepts relating to drug use and misuse in sport; how the problem is being tackled internationally through new research and surveillance; the role of healthcare providers in preventing doping in sport and how they can make a significant contribution at major sporting events and in the ongoing care of athletes. Current evidence-based clinical approaches to the prescription of medications and to supplement use in sports medicine will be addressed, with specific reference to recent relevant IOC consensus statements. The unique considerations relating to anti-doping for para-sports and athletes with impairments will be addressed specifically throughout the course.
The course will include 24 lectures that can be downloaded or watched online over a period of six months: each lecture lasts about 30-60 minutes, across the six module topics. Students will also be directed to a selection of mandatory and recommended reading from various reference sources. The official course reference text Drugs in Sport 7th edition (Routledge) will be provided to all students.
The first intake of students will begin their studies in September 2018.
1. Introduction to the use and misuse of drugs in sport
2. WADA, the Code and International Standards
3. Sports pharmacology and clinical use of medications in athletes
4. Protecting the health of the athlete and maintaining clean sport
5. Healthcare providers at major sporting events
6. New medicines and medical technologies and future implications in sport
- Doctors, pharmacists, nurses, and physiotherapists, especially those working in a sport setting and those who administer, prescribe or advise on drugs and supplements
- Graduates of existing IOC physiotherapy or IOC sports medicine diploma programs who require a more in-depth knowledge of anti-doping and drugs in sport
- Major Games (including Olympic and Paralympic) Organising Committee medical and anti-doping workforce, including volunteer and management staff
- Healthcare professionals working with athletes and sport teams
- Anti-doping organisations’ workforce
Assessment & Fees
To successfully complete the program, students must complete an online examination at the end of the course and must submit a self-reflection log which records their learning experience.
The tuition fee for the program is GBP £1650.00 which includes all course materials. VAT is applicable for all UK based students.
Requirements for acceptance to the course
Students must hold a relevant undergraduate degree in medicine, nursing, pharmacy, sports science, or an allied health science. They must be eligible to practice in their profession, and, where appropriate, registered with their national healthcare regulatory agency. Individuals able to demonstrate professional experience of working in the anti-doping environment may also be considered for admission.
English language proficiency is required.
Mr Mark Stuart (UK, Australia), International Olympic Committee Medical Commission Games Group
Prof David Mottram (UK), Liverpool John Moores University
Academic Advisory Board
Dr Cheri Blauwet (USA), International Paralympic Committee Medical Committee; Harvard Medical School
Dr Richard Budgett (Switzerland), International Olympic Committee Medical & Scientific Department
Dr Matt Fedoruk (USA), US Anti-Doping Agency
Dr Vidya Mohamed Ali (Qatar), IOC Medical & Scientific Commission; Anti-Doping Lab Qatar; University College London
Dr Alan Vernec (Canada), World Anti-Doping Agency
Lectures will be contributed by world-leading experts in the field, representing the best available expertise in the field. Faculty, in addition to the Course Directors and the Academic Advisory Board, who will all contribute lectures, include:
Prof Louis Phillipe Boulet (Canada), Université Laval
Dr Brian Hainline (USA), Indiana University School of Medicine; National Collegiate Athletic Association
Prof David Handelsman (Australia), University of Sydney
Dr Marylin Huestis (USA), WADA Prohibited List Expert Group; National Institute on Drug Abuse
Dr Audrey Kinahan (Ireland), WADA Prohibited List Expert Group
Dr Jamie Kissick (Canada), Canadian Medical Protective Association
Prof Ron Maughan (UK), St Andrews University
Dr Margo Mountjoy (Canada), International Olympic Committee Medical Commission Games Group; McMaster University
Dr John Orchard (Australia), University of Sydney
Prof Angela Schneider (Canada), University of Western Ontario
Dr Trudy Thomas (UK), Universities of Greenwich and Kent
Dr Susan White (Australia), Olympic Park Sports Medicine Centre
Dr David Zideman (UK), International Olympic Committee Medical Commission Games Group